Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, Mounjaro (tirzepatide) is still available in the UK as a prescription-only medicine for weight management. Supply constraints that affected availability in 2023 and 2024 have largely eased, and adults who meet the eligibility criteria can access it through a private regulated pharmacy following a clinical assessment — no referral or waiting list required for the private route. These are prescription medicines, so a qualified prescriber decides suitability after reviewing your health and circumstances. Tirzepatide's mechanism and evidence base are worth understanding before you start, and this page walks through how access actually works, step by step.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is a question our prescribers hear most weeks: someone has read about Mounjaro, wants to start, but isn't sure whether their BMI or health history qualifies. The licensed criteria under the UK marketing authorisation are straightforward. Adults with a BMI of 30 or above are in scope. Adults with a BMI between 27 and 29.9 are also eligible if they have at least one weight-related condition, type 2 diabetes, prediabetes, high blood pressure, high cholesterol, or obstructive sleep apnoea are common examples. Lower thresholds apply for some ethnic backgrounds under UK guidance, which your prescriber will account for.
BMI alone does not guarantee a prescription. The prescriber reviews your full picture: current medicines, medical history, and whether anything (certain thyroid conditions, a personal or family history of medullary thyroid carcinoma, or a history of pancreatitis, for instance) would make tirzepatide unsuitable. The full Mounjaro overview page covers the eligibility detail at length. Pregnancy, breastfeeding, and trying to conceive are situations where treatment is not recommended; the same applies to anyone under 18.
Getting clear on eligibility first saves time. If you're unsure, the consultation itself is the right place to find out, not a forum or a GP waiting room.
The NHS is rolling out Mounjaro in phases under NICE technology appraisal TA1026, which NICE published in December 2024. Cohort 1, for people with a BMI of 40 or above and four or more qualifying conditions, began in June 2025. Cohort 2 (BMI 35 to 39.9 with four or more conditions) activated in June 2026. Further cohorts are planned through 2027. NHS prescribing through GP practices under the new QOF contract is also possible from April 2026, though participation varies by practice. If you meet the current NHS criteria, it is worth asking your GP. If you do not meet them yet, or prefer not to wait, private access is the practical route now.
Private access through a GPhC-registered online pharmacy means no referral letter and no waiting list. A prescriber reviews your consultation the same day. If you're considering the private route, where to get Mounjaro safely explains what to look for in a legitimate provider, including how to check any pharmacy on the GPhC register at pharmacyregulation.org/registers.
For the private route, the process runs as follows. You complete a structured medical questionnaire covering your health history, current medicines, and weight. A GPhC-registered Independent Prescriber (a named clinician, not software) reads your answers and makes the clinical decision. If you're new to treatment, you'll also go through photo-ID verification and live weight confirmation on video, so the dose and suitability assessment is based on verified information.
Once approved, a prescription is issued and passed to the pharmacy for dispensing. At nume, orders placed by 12pm Monday to Friday are dispatched the same day through the licensed UK supply chain and delivered free the next working day by DPD, in plain unbranded packaging. There are no subscriptions; every repeat order is reviewed clinically before it goes out.
If you want to understand what happens after the first pen, what happens to weight loss when Mounjaro stops is a question worth reading up on before you commit to a plan. And for a broader look at weight management options alongside tirzepatide, the weight-loss treatment overview puts the options in context.
Mounjaro availability is generally stable across UK strengths as of mid-2026, though specific doses can occasionally be tighter than others. A legitimate pharmacy sources medicines through the authorised UK supply chain, if a dose is temporarily constrained, your prescriber discusses options rather than sourcing from an unregulated channel.
The counterfeit risk is real and worth stating plainly. The MHRA has warned repeatedly about fake weight-loss pens sold online and through social media, including via the Yellow Card reporting scheme. Some fake pens have contained insulin; others have contained no active ingredient at all. Sellers offering tirzepatide without a clinical assessment, at prices far below the market, or via social media are the clearest red flags. Check any pharmacy's GPhC registration before ordering. If you're looking at costs across providers, how Mounjaro pricing works in the UK gives honest context without any surprises.
One question that often comes up around this stage is whether you can still give blood while taking Mounjaro, and it is worth checking the guidance before your next donation appointment. If you've checked your eligibility and want to take the next step, start your free consultation with our prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.